GC and arthritic joint disease: By demonstrating that a single-monosaccharide “switch” on the vitamin D-binding protein scaffold can be leveraged to reprogramme macrophage fate in a spontaneous, large-joint disease, this trial extends a mechanistic continuum that spans in vitro human macrophage work and rodent arthritis models to a clinically relevant companion animal setting.